OQS
BLUE

Occudo Quantitative Strategies’s bluebird bio BLUE Stock Holding History

Occudo Quantitative Strategies’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-16,046
Closed -$1.56M – 1142
2022
Q1 		$1.56M Buy
+16,046
New +$2.12M 0.13% 249

Other funds holding BLUE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Occudo Quantitative Strategies's BLUE Position: Q2 2022 in Review

Occudo Quantitative Strategies sold out of bluebird bio (BLUE) in Q2 2022, closing a stake of 16,046 shares — an estimated $1.56M sold.

Occudo Quantitative Strategies first reported a position in BLUE in Q1 2022 and held it in 1 quarter. The position peaked at $1.56M in Q1 2022. 151 funds tracked by Wall St. Rank hold BLUE as of Q2 2022.

  • Occudo Quantitative Strategies reported no remaining bluebird bio position as of Q2 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 16,046 bluebird bio shares in Q2 2022, an estimated $1.56M.
  • Occudo Quantitative Strategies first reported a position in bluebird bio in Q1 2022 and held it in 1 quarter.
  • Occudo Quantitative Strategies's bluebird bio position peaked at $1.56M in Q1 2022.
  • 151 funds tracked by Wall St. Rank held bluebird bio as of Q2 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2022, filed 15 Aug 2022.